ÂÜÀòÂÒÂ×

Nadeem Mirza, M.D., M.P.H. has served as Senior Medical Advisor to Aprea since February 2023. Dr. Mirza brings over 30 years of clinical and developmental experience in solid tumors and hematologic malignancies. He currently serves as Senior Vice President, Clinical Development at Salarius Pharmaceuticals and previously served as Chief Medical Advisor at TRIGR Therapeutics developing bispecific antibodies. Prior to that, Dr. Mirza served as Senior Vice President, Corporate Medical Affairs at Verastem Oncology where he oversaw the launch of Copiktra®. Prior to Verastem, he served as Global Head Hematology and Solid Tumors at Abbvie Oncology where he oversaw the global launch of Venclexta®. Before Abbvie, he was Vice President, Head of Oncology, North America Medical Affairs at Sanofi Oncology where he was responsible for medical affairs programs to support 12 products across several oncology indications. Dr. Mirza has also held leadership roles in medical affairs and clinical development at Genzyme/Sanofi, Onyx Pharmaceuticals, Abraxis Oncology and Berlex Oncology. He holds an M.P.H. from the University of Texas at Houston, and earned his M.D. from the University of Punjab.